Skip to main content

Hidradenitis Suppurativa

Hidradenitis Suppurativa

Featured

Podcast
In this podcast, Michael Rosenblum, MD, reviews the pathophysiology of hidradenitis suppurativa and a possible immune activation signature that could potentially identify patients who may respond to TNF therapies.
News
A study published in the International Journal of Dermatology has reported that patients treated with a high dose of intralesional triamcinolone (ILTAC) for hidradenitis suppurativa (HS) have expresse
News
According to a recent study, inflammatory phenotype is associated with high C-reactive protein levels, showcasing the increased cardiovascular risk in patients with hidradenitis suppurativa.
Polls
Do you routinely screen for these diseases in your patients with HS? Let us know in the poll below!
News
Power-Doppler ultrasound assesses the persistence of fistulous tracts under treatment with adalimumab in hidradenitis suppurativa.
Back to Top